AGC Chemicals Americas Inc.

IRIX Pharmaceuticals, Inc. is a privately held company engaged in the generation of process technology for new and existing drugs.

IRIX offers the full capability of supplying API’s and complex pharma intermediates from pre-clinical stages, through all phases of clinical trials, registration/validation batches, launch and ongoing commercial quantities.

Formed to provide the Pharmaceutical Industry with a low-cost alternative for bringing new drugs to market rapidly, IRIX operates three sites for Process R&D and Clinical through Commercial cGMP production of API’s. Process R&D and early stage clinical supply for API’s is based in Florence, South Carolina. Late-stage clinical supply and commercial production is located in Greenville, South Carolina.

IRIX ensures compliance with all regulatory and quality requirements. Both the Greenville and Florence site were visited by the FDA in 2008 and 2009, respectively, with no 483s issued for either site.

IRIX supports new drug development in all functions necessary to bring a pharmaceutical candidate from discovery to market. IRIX provides seamless technology transfers both to/from Clients and internally for API syntheses.

The demonstrated expertise of the IRIX staff and the company’s emphasis on quality, economics, and timely delivery make it a choice CRMO (Contract Resources and Manufacturing Organization) for innovative pharmaceutical clients desiring to bring new drugs to the market rapidly.

Operating as an extension of the internal resources, IRIX offers sharp process solutions for an accelerated time to market at a very competitive cost.

Dow combines global breadth, asset integration and scale, focused innovation, and leading business positions to achieve profitable growth. Our ambition is to become the most innovative, customer-centric, inclusive, and sustainable materials science company, with a purpose to deliver a sustainable future for the world through our materials science expertise and collaboration with our partners. Our portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure, mobility, and consumer care. We operate 106 manufacturing sites in 31 countries and employ approximately 35,700 people.

A devision of ATTWILL Vascular Technologies, Attwill Medical Solutions purchased the assets of Anteco Pharma facility In 2017. Attwill Medical Solutions specializes in the lyophilization and related processing of pharmaceutical intermediates, medical devices and specialty food and nutritional ingredients.

ATTWILL operates a fully integrated commercialization business within a 36,500 square foot facility that includes R&D laboratories, piloting facilities and seven ISO 7 cleanrooms for manufacturing. Our ISO 13485 2016 manufacturing includes six freeze dryers that are used in the processing of ATTWILL products and in contract manufacturing of products that include pharmaceuticals, drug ingredients, medical devices, and nutraceuticals

Située sur la rive-sud de Montréal, Laboratoires Confab est spécialisée dans le développement et la fabrication de produits pharmaceutiques (CDMO). Des investissements majeurs sont en cours, dont un agrandissement de l’usine, afin de supporter la réalisation de ses projets en R&D et la commercialisation de nouvelles formes posologique novatrices en développement. L’entreprise évolue dans des contextes réglementaires canadiens et américains. Pour en connaître davantage sur notre entreprise : http://www.confab.com/french/

Confab specializes in the development and manufacturing of non-sterile pharmaceutical drugs (CDMO). The plant, located on the south shore of Montreal, is growing with major expansion investments underway to support an increasing volume of R&D projects as well as pioneering new dosage forms. The company complies with both Canadian and US regulatory requirements. To know more about Confab Laboratories please visit the website at http://www.confab.com/

Deseret Laboratories is a full service contract manufacturer of solid dose tablets/capsules and powders to nutraceutical (dietary supplement) products and OTC drugs with a specialty in Effervescents. We service the custom, direct marketing and retail industries. DLI also provides quality manufacturing of intermediates as granulations and Wurster coated API's or Nutritional powders. DLI has a full service R&D facility to assist customers in transforming their formulas to full-scale production. DLI also sells direct to the retail industry as OTC drugs, specializing in the effervescent products.